SCHEMBL5574178

SCHEMBL5574178

CCCN1CC[C@H](c2ccc(NS(=O)(=O)c3ccc(C(C)C)cc3)cc2)C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 7/20 0.52
DRD3 P35462 6/20 0.52
KCNH2 Q12809 5/20 0.52
SLC2A1 P11166 1/20 0.47
ALDH1A1 P00352 2/20 0.46
LMNA P02545 2/20 0.46
MAPT P10636 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
TP53 P04637 1/20 0.46
ATM Q13315 1/20 0.46
TRIM24 O15164 1/20 0.45
BRD1 O95696 1/20 0.45
BRPF1 P55201 1/20 0.45
PKM P14618 1/20 0.45
HTR6 P50406 2/20 0.44
POLB P06746 1/20 0.43
KDM2B Q8NHM5 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
DRD1 P21728 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1545866 1.00 DRD2 (0.52) DRD2DRD3KCNH2SLC2A1ALDH1A1
SCHEMBL1545864 1.00 DRD2 (0.52) DRD2DRD3KCNH2SLC2A1ALDH1A1
Hydrochloric Acid SCHEMBL1546697 0.99 DRD2 (0.51) DRD2DRD3KCNH2SLC2A1ALDH1A1
Hydrochloric Acid SCHEMBL1545749 0.99 DRD2 (0.51) DRD2DRD3KCNH2SLC2A1ALDH1A1
Hydrochloric Acid SCHEMBL1545751 0.99 DRD2 (0.51) DRD2DRD3KCNH2SLC2A1ALDH1A1
SCHEMBL1546428 0.94 DRD2 (0.50) DRD2DRD3KCNH2SLC2A1ALDH1A1
SCHEMBL5574905 0.93 ALDH1A1 (0.45) DRD2DRD3KCNH2SLC2A1ALDH1A1
SCHEMBL5574902 0.93 ALDH1A1 (0.45) DRD2DRD3KCNH2SLC2A1ALDH1A1
SCHEMBL1546424 0.92 DRD2 (0.56) DRD2DRD3KCNH2SLC2A1ALDH1A1
Hydrochloric Acid SCHEMBL1546989 0.92 ALDH1A1 (0.44) DRD2DRD3KCNH2SLC2A1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814849-A1 HETEROCYCLIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR Abbott GmbH & Co. KG (DE) 2007-08-08 EP disclosed
WO-2006040182-A1 HETEROCYCLIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR ABBOTT GMBH & CO. KG (DE) 2006-04-20 WO disclosed